Stockholders' Equity - Schedule of Activity in Warrants (Details) - Warrant [Member] - $ / shares |
3 Months Ended | ||
---|---|---|---|
Dec. 31, 2024 |
Jun. 30, 2025 |
Mar. 31, 2025 |
|
Schedule of Activity in Warrants [Line Items] | |||
Total Warrants, Issued (in Shares) | 32,020,286 | ||
Weighted Average Exercise Price, Issued | $ 0.29 | ||
Average Intrinsic Value, Issued | |||
Total Warrants, Exercised (in Shares) | (9,477,240) | ||
Weighted Average Exercise Price, Exercised | $ 0.29 | ||
Average Intrinsic Value, Exercised | |||
Total Warrants, Forfeited (in Shares) | (136,118) | ||
Weighted Average Exercise Price, Forfeited | $ 81.97 | ||
Average Intrinsic Value, Forfeited | |||
Total Warrants, Outstanding Ending Balance (in Shares) | 4,201,568 | 26,608,496 | 4,201,568 |
Weighted Average Remaining Term (Years), Outstanding Ending Balance | 2 years 25 days | 3 years 4 months 24 days | 1 year 9 months 18 days |
Weighted Average Exercise Price, Outstanding Ending Balance | $ 8.45 | $ 0.87 | $ 8.45 |
Average Intrinsic Value, Outstanding Ending Balance | $ 0.01 | $ 0.01 |
X | ||||||||||
- Definition The weighted average fair value at exercised date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were exercised during the reporting period. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of exercised award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Definition The average of intrinsic value is forfeited. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of Issued award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Definition Per share or unit weighted-average intrinsic value of award outstanding under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|